FGFR2 amplification was frequently found in the aggressive diffuse subtype from Lauren’s classification, and associated with lymphatic and venous invasion, lymph node metastasis, distant metastasis, advanced TNM stage, and poor prognosis. The gene discussed is FGFR2; the disease is metastatic malignant neoplasm in the lymph nodes.